⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ACIU News
AC Immune SA
AC Immune Presents New Phase 1 Data Indicating Higher Uptake of TDP-43 PET Tracer ACI-19626 in Patients with ALS
globenewswire.com
ACIU
Davos Alzheimer’s Collaborative Celebrates Andrea Pfeifer, Retiring CEO of AC Immune, for Her Contributions to Alzheimer’s Policy, Research and Care
globenewswire.com
ACIU
AC Immune Announces Retirement of CEO Dr Andrea Pfeifer at Upcoming AGM
globenewswire.com
ACIU
AC Immune First Quarter 2026 Financial and Corporate Updates
globenewswire.com
ACIU
AC Immune Initiates Final Cohort in Ongoing Phase 1b/2 ABATE Trial of Anti-Abeta Active Immunotherapy to Treat Alzheimer's Disease
globenewswire.com
ACIU
Targeted Alpha Therapy Market Landscape Report 2026-2030: Clinical Trials Insights on 30 Drugs - Size, Regulatory Approvals, Proprietary Technologies, Therapeutic Applications
globenewswire.com
ACIU
AZN
BMY
AC Immune Presents First In vivo Images of Brain TDP-43 Pathology from Phase 1 Trial of PET tracer ACI-19626, at AD/PDTM 2026
globenewswire.com
ACIU
AC Immune Reports Full Year 2025 Financial Results and Provides a Corporate Update
globenewswire.com
ACIU
AC Immune Announces Upcoming Industry Symposium on Parkinson’s Disease and Presentation at AD/PD™ 2026
globenewswire.com
ACIU
AC Immune Initiates Phase 1 Clinical Trial of NLRP3 Inhibitor
globenewswire.com
ACIU